Weighted Average Number of Shares Outstanding, Diluted of Inhibrx, Inc. from Q2 2020 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Inhibrx, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from Q2 2020 to Q1 2024.
  • Inhibrx, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Mar 2024 was 54.6M shares, a 25.2% increase year-over-year.
  • Inhibrx, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 47.1M shares, a 17.5% increase from 2022.
  • Inhibrx, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 40.1M shares, a 5.52% increase from 2021.
  • Inhibrx, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 38M shares, a 50.5% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Inhibrx, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 54.6M +11M +25.2% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2024
Q4 2023 47.1M +7.02M +17.5% 01 Oct 2023 31 Dec 2023 10-K 28 Feb 2024
Q3 2023 47.2M +8.08M +20.7% 01 Jul 2023 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 43.6M +4.6M +11.8% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2023
Q1 2023 43.6M +4.56M +11.7% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 40.1M +2.1M +5.52% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2024
Q3 2022 39.1M +1.18M +3.11% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 39M +1.22M +3.22% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023
Q1 2022 39M +1.28M +3.4% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023
Q4 2021 38M 01 Oct 2021 31 Dec 2021 10-K 06 Mar 2023
Q3 2021 37.9M +11.1M +41.7% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 37.8M +19.7M +108% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022
Q1 2021 37.7M 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q3 2020 26.8M 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021
Q2 2020 18.2M 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021

Inhibrx, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 47.1M +7.02M +17.5% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2024
2022 40.1M +2.1M +5.52% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2024
2021 38M +12.7M +50.5% 01 Jan 2021 31 Dec 2021 10-K 06 Mar 2023
2020 25.3M 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.